Insider transactions

EDGAR

PROTAGONIST THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
37 transactions, 850,859 shares
Sum of shares × price per share: 95,330,050.34

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 127

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-19 Filed 2026-11-20PATEL DINESH V PH D Director · Officer: President and CEO
G

Bona fide gift

Common Stock
Disposed (D)3000.00
0

Derived: shares × price per share. Exact value 0.00.

522,668Direct (D) No
F1
  • F1 This transaction involves a bona fide gift of securities from the Reporting Person to a relative.
Open filing 0001104659-26-130668 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-17MOLINA ARTURO MD Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,718124.65
338,798.7

Derived: shares × price per share. Exact value 338798.70.

81,397Direct (D) No
F1
  • F1 Sale of shares to cover tax withholding obligation incurred upon settlement of restricted stock units.
Open filing 0001104659-26-129244 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)9,22938.98
359,746.42

Derived: shares × price per share. Exact value 359746.42.

68,232Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)28,43823.42
666,017.96

Derived: shares × price per share. Exact value 666017.96.

96,670Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)15,65019.19
300,323.5

Derived: shares × price per share. Exact value 300323.50.

112,320Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,31212.17
64,647.04

Derived: shares × price per share. Exact value 64647.04.

117,632Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)12,595141.77
1,785,593.15

Derived: shares × price per share. Exact value 1785593.15.

105,037Direct (D) Yes
F1, F2
  • F1 The transactions set forth on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $140.21 to $143.31. Upon request by the staff of the U.S. Securities and Exchange Commission (the SEC), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)46,034141.78
6,526,700.52

Derived: shares × price per share. Exact value 6526700.52.

59,003Direct (D) Yes
F1, F3
  • F1 The transactions set forth on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2026.
  • F3 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $140.16 to $143.45. Upon request by the SEC, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (9,229) — exercise price 38.98
Disposed (D)9,2290—29,291Direct (D) Yes
F4
  • F4 The stock option vests in 48 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (28,438) — exercise price 23.42
Disposed (D)28,4380—49,562Direct (D) Yes
F5
  • F5 The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (15,650) — exercise price 19.19
Disposed (D)15,6500—51,150Direct (D) Yes
F6
  • F6 The stock option is fully vested.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-02Ali Asif Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (5,312) — exercise price 12.17
Disposed (D)5,3120—25,235Direct (D) Yes
F7
  • F7 The stock option vests in 48 equal monthly installments following January 16, 2023, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Open filing 0001104659-26-113279 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,27821.58
157,059.24

Derived: shares × price per share. Exact value 157059.24.

530,246Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,278144.10
1,048,759.8

Derived: shares × price per share. Exact value 1048759.80.

522,968Direct (D) Yes
F4
  • F4 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $142.51 to $145.19. Upon request by the staff of the SEC, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (7,278) — exercise price 21.58
Disposed (D)7,2780.00
0

Derived: shares × price per share. Exact value 0.00.

0Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)63,54821.58
1,371,365.84

Derived: shares × price per share. Exact value 1371365.84.

586,516Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)63,548146.18
9,289,446.64

Derived: shares × price per share. Exact value 9289446.64.

522,968Direct (D) Yes
F3
  • F3 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $144.49 to $151.27. Upon request by the staff of the SEC, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (63,548) — exercise price 21.58
Disposed (D)63,5480.00
0

Derived: shares × price per share. Exact value 0.00.

7,278Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)54,17421.58
1,169,074.92

Derived: shares × price per share. Exact value 1169074.92.

577,142Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)54,174145.87
7,902,361.38

Derived: shares × price per share. Exact value 7902361.38.

522,968Direct (D) Yes
F2
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $142.00 to $147.29. Upon request by the staff of the U.S. Securities and Exchange Commission (the SEC), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (54,174) — exercise price 21.58
Disposed (D)54,1740.00
0

Derived: shares × price per share. Exact value 0.00.

70,826Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-106831 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-08PATEL DINESH V PH D Director · Officer: President and CEO
G

Bona fide gift

Common Stock
Disposed (D)5100.00
0

Derived: shares × price per share. Exact value 0.00.

522,968Direct (D) No
F1
  • F1 This transaction involves a bona fide gift of securities from the Reporting Person to relatives.
Open filing 0001104659-26-105955 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)34,23921.58
738,877.62

Derived: shares × price per share. Exact value 738877.62.

557,717Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)34,239148.52
5,085,176.28

Derived: shares × price per share. Exact value 5085176.28.

523,478Direct (D) Yes
F3
  • F3 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $147.64 to $151.30. Upon request by the staff of the SEC, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (34,239) — exercise price 21.58
Disposed (D)34,2390.00
0

Derived: shares × price per share. Exact value 0.00.

125,000Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-12PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)65,76121.58
1,419,122.38

Derived: shares × price per share. Exact value 1419122.38.

589,239Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-12PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)65,761149.11
9,805,622.71

Derived: shares × price per share. Exact value 9805622.71.

523,478Direct (D) Yes
F2
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $147.41 to $151.29. Upon request by the staff of the U.S. Securities and Exchange Commission (the SEC), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-12PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (65,761) — exercise price 21.58
Disposed (D)65,7610.00
0

Derived: shares × price per share. Exact value 0.00.

159,239Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026. The 10b5-1 plan provides for the exercise of fully vested stock options that expire on October 11, 2026, and the sale of shares of common stock acquired upon exercise of the stock options.
Open filing 0001104659-26-095111 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-25Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)9,00016.54
148,860

Derived: shares × price per share. Exact value 148860.00.

16,825Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 27, 2026.
Open filing 0001104659-26-077761 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-25Waddill William D. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,000117.94
1,061,460

Derived: shares × price per share. Exact value 1061460.00.

7,825Direct (D) Yes
F2
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $117.00 to $119.07. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-077761 Read from the filing’s XML Dispute this row
2026-06-23 Filed 2026-06-25Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (9,000) — exercise price 16.54
Disposed (D)9,0000.00
0

Derived: shares × price per share. Exact value 0.00.

0Direct (D) Yes
F3
  • F3 These stock options are fully vested.
Open filing 0001104659-26-077761 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)3,00011.8
35,400

Derived: shares × price per share. Exact value 35400.0.

10,825Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 27, 2026.
Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)6,00016.54
99,240

Derived: shares × price per share. Exact value 99240.00.

16,825Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 27, 2026.
Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Waddill William D. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,000107.68
969,120

Derived: shares × price per share. Exact value 969120.00.

7,825Direct (D) Yes
F2
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $107.02 to $108.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (3,000) — exercise price 11.8
Disposed (D)3,0000.00
0

Derived: shares × price per share. Exact value 0.00.

0Direct (D) Yes
F3
  • F3 These stock options are fully vested.
Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (6,000) — exercise price 16.54
Disposed (D)6,0000.00
0

Derived: shares × price per share. Exact value 0.00.

9,000Direct (D) Yes
F3
  • F3 These stock options are fully vested.
Open filing 0001104659-26-073049 Read from the filing’s XML Dispute this row
2026-05-29 Filed 2026-06-01Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)9,00011.8
106,200

Derived: shares × price per share. Exact value 106200.0.

16,825Direct (D) Yes
F1
  • F1 The transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 27, 2026.
Open filing 0001104659-26-069047 Read from the filing’s XML Dispute this row
2026-05-29 Filed 2026-06-01Waddill William D. Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,00099.64
896,760

Derived: shares × price per share. Exact value 896760.00.

7,825Direct (D) Yes— Open filing 0001104659-26-069047 Read from the filing’s XML Dispute this row
2026-05-29 Filed 2026-06-01Waddill William D. Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (9,000) — exercise price 11.8
Disposed (D)9,0000.00
0

Derived: shares × price per share. Exact value 0.00.

3,000Direct (D) Yes
F2
  • F2 These stock options are fully vested.
Open filing 0001104659-26-069047 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-14PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)75,00021.58
1,618,500

Derived: shares × price per share. Exact value 1618500.00.

598,478Direct (D) Yes
F1
  • F1 This Form 4 Amendment is being filed to clarify that the transactions set forth on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on January 30, 2026 and to check the appropriate box which appeared unchecked on the original Form 4 filing.
Open filing 0001104659-26-061476 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-14PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)75,000100.12
7,509,000

Derived: shares × price per share. Exact value 7509000.00.

523,478Direct (D) Yes
F2
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $98.83 to $103.50. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-061476 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-14PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (75,000) — exercise price 21.58
Disposed (D)75,0000.00
0

Derived: shares × price per share. Exact value 0.00.

225,000Direct (D) Yes
F3
  • F3 These stock options are fully vested and will expire on October 11, 2026.
Open filing 0001104659-26-061476 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-12PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)75,00021.58
1,618,500

Derived: shares × price per share. Exact value 1618500.00.

598,478Direct (D) No— Open filing 0001104659-26-059591 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-12PATEL DINESH V PH D Director · Officer: President and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)75,000100.12
7,509,000

Derived: shares × price per share. Exact value 7509000.00.

523,478Direct (D) No
F1
  • F1 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $98.83 to $103.50. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-059591 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-12PATEL DINESH V PH D Director · Officer: President and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (right to buy) — underlying Common Stock (75,000) — exercise price 21.58
Disposed (D)75,0000.00
0

Derived: shares × price per share. Exact value 0.00.

225,000Direct (D) No
F2
  • F2 These stock options are fully vested and will expire on October 11, 2026.
Open filing 0001104659-26-059591 Read from the filing’s XML Dispute this row
2026-05-08 Filed 2026-05-11Giraudo Bryan Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,000100.00
600,000

Derived: shares × price per share. Exact value 600000.00.

0Indirect (I) By Bryan Courtney Giraudo TrustNo— Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row
2026-05-08 Filed 2026-05-11Giraudo Bryan Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,130100.00
513,000

Derived: shares × price per share. Exact value 513000.00.

12,695Direct (D) No— Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-11Giraudo Bryan Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)24,0006.45
154,800

Derived: shares × price per share. Exact value 154800.00.

31,825Direct (D) No
F1
  • F1 Reflects 10,000 shares of common stock that were previously held directly by the Reporting Person and which were transferred to the Bryan Courtney Giraudo Trust.
Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-11Giraudo Bryan Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)12,0006.98
83,760

Derived: shares × price per share. Exact value 83760.00.

43,825Direct (D) No— Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-11Giraudo Bryan Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)36,000100.14
3,605,040

Derived: shares × price per share. Exact value 3605040.00.

27,825Direct (D) No
F2
  • F2 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $98.69 to $104.67. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Open filing 0001104659-26-058860 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BlackRock, Inc. Common Stock15.29,834,14609/30/2026 Filed 2026-10-27SCHEDULE 13G/AAmendment 8Open filing 0002012383-26-003834 Dispute this row
Farallon Capital Management, L.L.C. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital Institutional Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital Institutional Partners II, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital Institutional Partners III, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Four Crossings Institutional Partners V, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital Offshore Investors II, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital (AM) Investors, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Capital F5 Master I, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Healthcare Partners Master, L.P. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Partners, L.L.C. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Institutional (GP) V, L.L.C. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon F5 (GP), L.L.C. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Farallon Healthcare Partners (GP), L.L.C. Common Stock, par value $0.00001 per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Dapice Joshua J. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Dreyfuss, Philip D. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Dunn Hannah E. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Gehani, Varun N. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Giauque, Nicolas Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Husen, Avner A. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Kim, David T. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Linn, Michael G. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Luo Patrick (Cheng) Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Roberts, Jr., Thomas G. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Saito Edric C. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Short Daniel S. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Spokes, Andrew J. M. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Warren, John R. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
Wehrly, Mark C. Common Stock, par value $0.00001 per share (the "Shares")9.996,433,11906/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 9Open filing 0000908834-26-000405 Dispute this row
STATE STREET CORPORATION COMMON STOCK5.23,321,554.0006/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000093751-26-000527 Dispute this row
STATE STREET CORPORATION COMMON STOCK4.93,116,804.0003/31/2026 Filed 2026-05-12SCHEDULE 13GOpen filing 0000093751-26-000283 Dispute this row
Vanguard Capital Management Common Stock5.093,250,00303/31/2026 Filed 2026-04-30SCHEDULE 13GOpen filing 0002100119-26-000884 Dispute this row
Vanguard Portfolio Management Common Stock5.533,533,01503/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100121-26-000589 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 5Open filing 0000102909-26-002110 Dispute this row
RTW Investments, LP Common Stock, $0.00001 par value8.15,059,053.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 6Open filing 0001493215-26-000042 Dispute this row
Roderick Wong Common Stock, $0.00001 par value8.15,059,053.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 6Open filing 0001493215-26-000042 Dispute this row
Wellington Management Group LLP Common Stock5.13,171,423.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000033 Dispute this row
Wellington Group Holdings LLP Common Stock5.13,171,423.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000033 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock5.13,171,423.0012/31/2025 Filed 2026-02-10SCHEDULE 13GOpen filing 0000902219-26-000033 Dispute this row
Farallon Capital Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.5283,06212/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Capital Institutional Partners, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.5290,85012/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Capital Institutional Partners II, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.191,42112/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Capital Institutional Partners III, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.139,41712/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Four Crossings Institutional Partners V, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.153,34312/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Capital Offshore Investors II, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.9565,08012/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Capital (AM) Investors, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.136,18112/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Capital F5 Master I, L.P. Common Stock, par value $0.00001 per share (the "Shares")0.2121,09412/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Healthcare Partners Master, L.P. Common Stock, par value $0.00001 per share (the "Shares")7.64,767,56412/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row
Farallon Partners, L.L.C. Common Stock, par value $0.00001 per share (the "Shares")9.86,126,91912/31/2025 Filed 2026-02-06SCHEDULE 13G/AAmendment 8Open filing 0000908834-26-000054 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,715,586 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015131,968
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to PROTAGONIST THERAPEUTICS, INC.